arrow
A

Alberto Puccini

IRCCS Humanitas Research Hospital
H指数:30
被引数:4,755

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Legal Frameworks, Institutional Barriers and Unmet Needs of Young University Students With Cancer in Italy: A Call to Action

意大利年轻癌症大学生的法律框架、制度障碍和未满足的需求:行动呼吁

2026-10-230
OA
Mismatch repair deficiency or microsatellite instability in locally advanced rectal cancer patients treated with total neoadjuvant therapy

局部晚期直肠癌患者接受总新辅助治疗后出现错配修复缺陷或微卫星不稳定性

2026-07-020
PRE
Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer (vol 5, 100069, 2025)

立体定向放射治疗联合帕博利珠单抗治疗错配修复缺陷/微卫星不稳定型转移性结直肠癌的可行性(卷5,100069,2025)

2026-01-010
OAAI
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world dataset

pT4N0结肠癌的预后影响与临床管理:来自大型、多中心、国际、真实世界数据集的数据

2025-07-150
OAAI
Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: the multicentre, phase II randomized TRINITY trial
2025-04-080
OAAI
Prognostic impact of depth of response and early tumour shrinkage in patients with BRAFV600E-mutated metastatic colorectal cancer treated with targeted therapy
2025-01-070
OAAI
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study

错配修复缺陷局部晚期直肠癌患者的治愈性免疫检查点抑制剂治疗: 一项真实世界观察性研究

2024-10-010
OAAI
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.

意大利多中心胰腺癌患者癌症易感性基因的种系致病变异。

2024-09-010
PRE
Impact of RAS and BRAFV600E mutations on tumor immune microenvironment and associated genomic alterations in patients with microsatellite instability (MSI) or DNA mismatch repair deficient (dMMR) colorectal cancers

RAS和 BRAFV600E 突变对微卫星不稳定(MSI)或DNA错配修复缺陷(dMMR)结直肠癌患者肿瘤免疫微环境及相关基因组改变的影响

2024-09-011
PRE
Correlation between pathological complete response (pCR) and survival outcomes in patients with resectable esophageal (EC) or gastroesophageal junction cancer (GEJC): A large, real-world, single-center cohort analysis
2024-06-010
PRE
Adjuvant trastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surgery: The TRINITY trial
2024-06-011
PRE